会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • FLEA ULTRASPIRACLE NUCLEIC ACID MOLECULES
    • FLEA ULTRASPIRACLE核酸分子
    • US20070231894A1
    • 2007-10-04
    • US11697551
    • 2007-04-06
    • Nancy WisnewskiAnna BecherEric Jarvis
    • Nancy WisnewskiAnna BecherEric Jarvis
    • C07H21/04C12N15/00C12N5/06
    • C07K14/4359C07K14/721Y10S530/858
    • The present invention relates to flea ecdysone receptor and ultraspiracle proteins; to flea ecdysone receptor and ultraspiracle nucleic acid molecules, including those that encode such flea ecdysone receptor and ultraspiracle proteins; to antibodies raised against such flea ecdysone receptor and ultraspiracle proteins; and to compounds that inhibit flea ecdysone receptor and/or ultraspiracle activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising a protective compound derived from a protein of the present invention that inhibits the binding between ecdysone receptor and ecdysone as well as the use of such therapeutic compositions to protect animals from flea infestation.
    • 本发明涉及跳蚤蜕皮激素受体和超尖锐蛋白质; 跳蚤蜕皮激素受体和超尖锐核酸分子,包括那些编码这种跳蚤蜕皮激素受体和超尖锐蛋白质的分子; 针对这种跳蚤蜕皮激素受体和超尖锐蛋白的抗体; 以及抑制跳蚤蜕皮激素受体和/或超急性活性的化合物。 本发明还包括获得这些蛋白质,核酸分子,抗体和抑制性化合物的方法。 本发明还包括包含抑制蜕皮激素受体和蜕皮激素之间结合的本发明蛋白质的保护性化合物的治疗组合物,以及这些治疗组合物用于保护动物免于跳蚤侵染的治疗组合物。
    • 3. 发明授权
    • Flea ecdysone and ultraspiracle nucleic acid molecules, proteins and uses thereof
    • 跳蚤蜕皮激素和超尖锐核酸分子,蛋白质及其用途
    • US06489140B1
    • 2002-12-03
    • US09435019
    • 1999-11-05
    • Nancy WisnewskiAnna M. BecherEric Jarvis
    • Nancy WisnewskiAnna M. BecherEric Jarvis
    • C12P2106
    • C07K14/4359C07K14/721Y10S530/858
    • The present invention relates to flea ecdysone receptor and ultraspiracle proteins; to flea ecdysone receptor and ultraspiracle nucleic acid molecules, including those that encode such flea ecdysone receptor and ultraspiracle proteins; to antibodies raised against such flea ecdysone receptor and ultraspiracle proteins; and to compounds that inhibit flea ecdysone receptor and/or ultraspiracle activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising a protective compound derived from a protein of the present invention that inhibits the binding between ecdysone receptor and ecdysone as well as the use of such therapeutic compositions to protect animals from flea infestation.
    • 本发明涉及跳蚤蜕皮激素受体和超尖锐蛋白质; 跳蚤蜕皮激素受体和超尖锐核酸分子,包括那些编码这种跳蚤蜕皮激素受体和超尖锐蛋白质的分子; 针对这种跳蚤蜕皮激素受体和超尖锐蛋白的抗体; 以及抑制跳蚤蜕皮激素受体和/或超急性活性的化合物。 本发明还包括获得这些蛋白质,核酸分子,抗体和抑制性化合物的方法。 本发明还包括包含抑制蜕皮激素受体和蜕皮激素之间结合的本发明蛋白质的保护性化合物的治疗组合物,以及这些治疗组合物用于保护动物免于跳蚤侵染的治疗组合物。
    • 4. 发明授权
    • Flea ultraspiracle nucleic acid molecules
    • 跳蚤超尖锐核酸分子
    • US07667019B2
    • 2010-02-23
    • US11697551
    • 2007-04-06
    • Nancy WisnewskiAnna M. BecherEric Jarvis
    • Nancy WisnewskiAnna M. BecherEric Jarvis
    • C07H21/04A61K38/00
    • C07K14/4359C07K14/721Y10S530/858
    • The present invention relates to flea ecdysone receptor and ultraspiracle proteins; to flea ecdysone receptor and ultraspiracle nucleic acid molecules, including those that encode such flea ecdysone receptor and ultraspiracle proteins; to antibodies raised against such flea ecdysone receptor and ultraspiracle proteins; and to compounds that inhibit flea ecdysone receptor and/or ultraspiracle activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising a protective compound derived from a protein of the present invention that inhibits the binding between ecdysone receptor and ecdysone as well as the use of such therapeutic compositions to protect animals from flea infestation.
    • 本发明涉及跳蚤蜕皮激素受体和超尖锐蛋白质; 跳蚤蜕皮激素受体和超尖锐核酸分子,包括那些编码这种跳蚤蜕皮激素受体和超尖锐蛋白质的分子; 针对这种跳蚤蜕皮激素受体和超尖锐蛋白的抗体; 以及抑制跳蚤蜕皮激素受体和/或超急性活性的化合物。 本发明还包括获得这些蛋白质,核酸分子,抗体和抑制性化合物的方法。 本发明还包括包含抑制蜕皮激素受体和蜕皮激素之间结合的本发明蛋白质的保护性化合物的治疗组合物,以及这些治疗组合物用于保护动物免于跳蚤侵染的治疗组合物。
    • 5. 发明授权
    • Flea ecdysone nucleic acid molecules and uses thereof
    • 跳蚤蜕皮激素核酸分子及其用途
    • US06767721B2
    • 2004-07-27
    • US10065200
    • 2002-09-25
    • Nancy WisnewskiAnna M. BecherEric Jarvis
    • Nancy WisnewskiAnna M. BecherEric Jarvis
    • C12P2106
    • C07K14/4359C07K14/721Y10S530/858
    • The present invention relates to flea ecdysone receptor and ultraspiracle proteins; to flea ecdysone receptor and ultraspiracle nucleic acid molecules, including those that encode such flea ecdysone receptor and ultraspiracle proteins; to antibodies raised against such flea ecdysone receptor and ultraspiracle proteins; and to compounds that inhibit flea ecdysone receptor and/or ultraspiracle activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising a protective compound derived from a protein of the present invention that inhibits the binding between ecdysone receptor and ecdysone as well as the use of such therapeutic compositions to protect animals from flea infestation.
    • 本发明涉及跳蚤蜕皮激素受体和超尖锐蛋白质; 跳蚤蜕皮激素受体和超尖锐核酸分子,包括那些编码这种跳蚤蜕皮激素受体和超尖锐蛋白质的分子; 针对这种跳蚤蜕皮激素受体和超尖锐蛋白的抗体; 以及抑制跳蚤蜕皮激素受体和/或超急性活性的化合物。 本发明还包括获得这些蛋白质,核酸分子,抗体和抑制性化合物的方法。 本发明还包括包含抑制蜕皮激素受体和蜕皮激素之间结合的本发明蛋白质的保护性化合物的治疗组合物,以及这些治疗组合物用于保护动物免于跳蚤侵染的治疗组合物。
    • 9. 发明授权
    • Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
    • 跳蚤头,神经线,后肠和恶臭小管核酸分子,蛋白质及其用途
    • US08088903B2
    • 2012-01-03
    • US11565729
    • 2006-12-01
    • Kevin S. BrandtPatrick J. GainesDan T. StinchcombNancy Wisnewski
    • Kevin S. BrandtPatrick J. GainesDan T. StinchcombNancy Wisnewski
    • C07H21/02C07H21/04
    • C07K14/4359
    • The present invention relates to flea head, nerve cord, hindgut and Malpighian tubule proteins; to flea head, nerve cord, hindgut and Malpighian tubule nucleic acid molecules, including those that encode such flea head, nerve cord, hindgut and Malpighian tubule proteins; to antibodies raised against such flea head, nerve cord, hindgut and Malpighian tubule proteins; and to compounds that inhibit flea head, nerve cord, hindgut and Malpighian tubule protein activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising proteins, nucleic acid molecules, antibodies, or protective compounds derived from proteins of the present invention as well as the use of such therapeutic compositions to protect animals from flea infestation. Also included in the present invention is the use of flea head, nerve cord, hindgut and Malpighian tubule proteins to derive inhibitory compounds.
    • 本发明涉及跳蚤头,神经根,后肠和马鞭状小管蛋白; 跳蚤头,神经线,后肠和马鞭状小管核酸分子,包括编码这种跳蚤头,神经线,后肠和马鞭状小管蛋白的那些; 针对这种跳蚤头,神经线,后肠和马鞭状小管蛋白质产生的抗体; 以及抑制跳蚤头,神经丝,后肠和马鞭状小管蛋白活性的化合物。 本发明还包括获得这些蛋白质,核酸分子,抗体和抑制性化合物的方法。 本发明还包括包含衍生自本发明蛋白质的蛋白质,核酸分子,抗体或保护性化合物的治疗组合物,以及这些治疗组合物用于保护动物免于跳蚤侵染的治疗组合物。 本发明还包括使用跳蚤头,神经根,后肠和马鞭状小管蛋白来衍生抑制性化合物。
    • 10. 发明授权
    • Canine cox-2 nucleic acid molecules and uses thereof
    • 犬cox-2核酸分子及其用途
    • US06638744B2
    • 2003-10-28
    • US09919060
    • 2001-07-31
    • Nancy WisnewskiKevin S. Brandt
    • Nancy WisnewskiKevin S. Brandt
    • C12N902
    • A61K31/7088C12N9/90
    • The present invention relates to canine COX-1 and COX-2 proteins; to canine COX-1 and COX-2 nucleic acid molecules, including those that encode such COX-1 and COX-2 proteins, respectively; to antibodies raised against such proteins; and to compounds that inhibit the activity of such proteins. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. The present invention also includes therapeutic compositions comprising such inhibitory compounds, particularly those that specifically inhibit COX-2 activity, as well as the use of such therapeutic compositions to treat animals.
    • 本发明涉及犬COX-1和COX-2蛋白; 涉及犬COX-1和COX-2核​​酸分子,包括分别编码这种COX-1和COX-2蛋白的那些; 针对这种蛋白质产生的抗体; 以及抑制这些蛋白质活性的化合物。 本发明还包括获得这些蛋白质,核酸分子,抗体和抑制性化合物的方法。 本发明还包括包含这种抑制性化合物,特别是特异性抑制COX-2活性的抑制性化合物的治疗组合物,以及这些治疗组合物用于治疗动物的用途。